Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,114.00
Bid: 4,070.00
Ask: 4,182.00
Change: 0.00 (0.00%)
Spread: 112.00 (2.752%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,114.00
CRDA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of German Oleochemicals Business

10 May 2010 07:00

RNS Number : 6012L
Croda International PLC
10 May 2010
 



10 May 2010

 

Croda International Plc

 

Sale of German Oleochemicals Business

 

Croda International Plc ("Croda") announces that it has agreed to sell its Emmerich Site and associated business in Germany to KLK Emmerich GmbH, a subsidiary of the KLK Group (Kuala Lumpur Kepong Berhad), for €60.5 million. As part of the transaction the purchaser will assume IAS19 retirement benefit obligations relating to the business of approximately €35.2 million such that cash payable at completion will be €25.3 million. The disposal largely completes Croda's restructuring programme to re-position its oleochemical operations following the acquisition of Uniqema in 2006.

 

The Emmerich Site produces fatty acids and glycerine, most of which were sold into Croda's Industrial Specialities market. Croda acquired the Emmerich site as part of the Uniqema acquisition. On a pro-forma basis the business had sales of £80.0m and made an operating loss of £2.1million in 2009, with net operating assets of £37.7 million at 31 December 2009.

 

Completion is subject to German anti-trust clearance and Malaysian Central Bank approval. The agreement contains warranties customary in a transaction of this nature and size and is subject to adjustments for actual working capital employed and retirement benefit obligations at completion. Croda will continue to supply and source some products to and from the business under normal third party commercial terms.

 

The sales proceeds will initially be used to reduce Croda's net debt which stood at £292.7 million at 31 March 2010. The transaction is expected to be marginally earnings enhancing in the year ending 31 December 2010 (see note).

 

 

For further information:

 

Sean Christie, Group Finance Director

Tel: 01405 860551

Charles Armitstead, Financial Dynamics

Tel: 020 7269 7275

 

 

Note

 

This statement should not be taken to mean that earnings per share (before any one-off costs or amortisation of intangibles) of Croda will necessarily be higher than historic earnings per share (before any one-off costs or amortisation of intangibles) of Croda and no forecast is intended or implied.

 

 

Croda International Plc quarterly results excluding Emmerich

 

 

2009

 

2009

 

2009

 

2009

 

2009

 

2010

 

Q1

 

Q2

 

Q3

 

Q4

 

Year

 

Q1

Turnover

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumer Care

126.3

 

106.8

 

113.6

 

111.7

 

458.4

 

128.2

Industrial Specialities

85.9

 

90.1

 

99.5

 

102.3

 

377.8

 

121.3

 

 

 

 

 

 

 

 

 

 

 

 

 

212.2

 

196.9

 

213.1

 

214.0

 

836.2

 

249.5

 

 

 

 

 

 

 

 

 

 

 

 

Profits

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumer Care

28.7

 

24.1

 

24.6

 

26.2

 

103.6

 

34.7

Industrial Specialities

(0.4)

 

1.3

 

8.5

 

9.0

 

18.4

 

11.4

 

 

 

 

 

 

 

 

 

 

 

 

 

28.3

 

25.4

 

33.1

 

35.2

 

122.0

 

46.1

Interest

(4.6)

 

(2.8)

 

(2.8)

 

(3.3)

 

(13.5)

 

(2.7)

 

 

 

 

 

 

 

 

 

 

 

 

 

23.7

 

22.6

 

30.3

 

31.9

 

108.5

 

43.4

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISGUGDUDXBBGGG
Date   Source Headline
13th Jun 20249:46 amRNSHolding(s) in Company
12th Jun 20249:01 amRNSDirector/PDMR Shareholding
11th Jun 20242:12 pmRNSDirector/PDMR Shareholding
30th May 20243:27 pmRNSDirector/PDMR Shareholding
30th May 20242:33 pmRNSDirector/PDMR Shareholding
13th May 20242:16 pmRNSDirector/PDMR Shareholding
2nd May 20249:27 amRNSDirector/PDMR Shareholding
1st May 202412:18 pmRNSDirector/PDMR Shareholding
25th Apr 202410:01 amRNSResult of AGM
24th Apr 20247:00 amRNSFirst quarter 2024 sales update
11th Apr 20242:11 pmRNSDirector/PDMR Shareholding
8th Apr 202410:54 amRNSDirector/PDMR Shareholding
8th Apr 202410:23 amRNSDirector/PDMR Shareholding
28th Mar 20249:17 amRNSDirector/PDMR Shareholding
26th Mar 20244:19 pmRNSDirector/PDMR Shareholding
26th Mar 20244:10 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSDirector/PDMR Shareholding
26th Mar 20244:06 pmRNSDirector/PDMR Shareholding
26th Mar 20244:04 pmRNSDirector/PDMR Shareholding
15th Mar 20249:32 amRNSAnnual Financial Report
12th Mar 20242:49 pmRNSDirector/PDMR Shareholding
7th Mar 20243:03 pmRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSResults for the year ended 31 December 2023
13th Feb 20243:35 pmRNSDirector/PDMR Shareholding
9th Feb 20243:28 pmRNSHolding(s) in Company
18th Jan 20241:33 pmRNSHolding(s) in Company
11th Jan 20243:17 pmRNSDirector/PDMR Shareholding
18th Dec 20237:00 amRNSDirectorate Change
12th Dec 20233:08 pmRNSDirector/PDMR Shareholding
11th Dec 202311:39 amRNSDirector Declaration
29th Nov 20234:54 pmRNSHolding(s) in Company
28th Nov 20239:35 amRNSDirector/PDMR Shareholding
24th Nov 202311:33 amRNSHolding(s) in Company
14th Nov 20239:40 amRNSDirector/PDMR Shareholding
19th Oct 202311:19 amRNSHolding(s) in Company
19th Oct 202310:34 amRNSDirector/PDMR Shareholding
12th Oct 202311:46 amRNSDirector/PDMR Shareholding
9th Oct 20237:00 amRNSThird Quarter Trading Update
6th Oct 20234:12 pmRNSDirector/PDMR Shareholding
5th Oct 20238:53 amRNSHolding(s) in Company
3rd Oct 20234:03 pmRNSDirector/PDMR Shareholding
27th Sep 20235:17 pmRNSDirector/PDMR Shareholding
26th Sep 202311:38 amRNSDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSDirectorate Change
15th Sep 202311:51 amRNSDirector/PDMR Shareholding
12th Sep 20234:01 pmRNSDirector/PDMR Shareholding
12th Sep 20238:56 amRNSDirector/PDMR Shareholding
11th Aug 20232:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.